The first domestic treatment of new crown oral medicine was approved!

Author:Hebei Radio and Television Sta Time:2022.07.25

According to the website of the State Drug Administration, on July 25, in accordance with the relevant provisions of the Drug Management Law, the State Drug Administration shall conduct emergency review and approval in accordance with the special approval procedures for the drug, and approve the conditions of Henan Real Biotechnology Co., Ltd. Azf Increase application for the treatment of new coronary virus pneumonia adaptation.

Azf's fixed film is the treatment of oral small molecular virus pneumonia therapy drugs independently developed by my country. On July 20, 2021, the State Drug Administration has attached conditions to approve this product and other reverse-translitease inhibitors to treat adult HIV-1 infection patients with high virus load. This is an attachment to approve new indications for the treatment of adult patients with COVID-19) for the treatment of ordinary new type of coronary virus pneumonia. Patients should be used strictly under the guidance of the doctor.

The State Drug Administration requires listing permit holders to continue to carry out relevant research work, complete the requirements for qualified conditions within a time limit, and submit subsequent research results in a timely manner.

According to Henan Daily, the State Drug Administration formally approved Henan Real Biotechnology Co., Ltd. to apply for the application of Intonal Class I Innovation Pharmaceutical Azf fixed tablet to increase the application of new coronary virus pneumonia indications. Small molecules are officially approved.

At present, Azf has the basic conditions for the entire industrial chain from R & D, raw medicine, preparation to produce, preparation production, and sales headquarters.